Received Jul 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | YC239 | — |
Patient was given Infanrix that was 4 days expired; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 6-year-old female patient who received DTPa (Infanrix) (batch number YC239, expiry date 13-JUL-2025) for prophylaxis. On 17-JUL-2025, the patient received Infanrix. On 17-JUL-2025, an unknown time after receiving Infanrix, the patient experienced expired vaccine used (Verbatim: Patient was given Infanrix that was 4 days expired). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 17-JUL-2025 The reporter mentioned that a patient was given Infanrix that was 4 days expired, which led to expired vaccine used Consent to follow up granted.